"The air sacs in the lungs are a critical first barrier against infections in humans, but we've traditionally looked at them ...

Authored by - Chapal Mehra, public health specialist, New Delhi and Zarir Udwadia, consultant physician, Hinduja and Breach ...

Tuberculosis (TB) remains one of humanity’s oldest and most persistent health challenges. Despite significant medical advances, this infectious disease continues to affect millions globally, with ...

The immune system remains seriously out-of-whack – in an inflammatory state of overactivation and impaired functionality – ...

Antimicrobial stewardship (AMS) refers to coordinated strategies for the targeted, evidence-based, and safe use of ...

AS a director of the Philippine Tuberculosis Society, Inc. (PTSI), my advocacy extends beyond treating TB — it must also confront one of the strongest drivers of the disease: smoking in all its forms, ...

Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...

Adjunctive corticosteroids may reduce mortality from all forms of tuberculosis by 17%, no matter which organ group was affected, according to a meta-analysis. Julia A. Critchley, DPhil, from the ...

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

Reports of TB date back to around 410-400 B.C.E., when the physician Hippocrates termed the disease phthisis, an archaic word that means a progressive “wasting away,” due to the way people with the ...

A University of Virginia-led team of researchers has made a discovery that may change sepsis treatment for patients in Africa ...

Ocular TB is a rare eye disease due to infection from Mycobacterium tuberculosis, the same bacterium that causes tuberculosis, commonly known as TB. TB symptoms usually start in the lungs, but they ...